Dissolution Testing: Medium, Deaeration, Temperature and Sampling

A qualified dissolution apparatus can still produce unreliable results if the medium, starting conditions or sampling sequence differ from the approved procedure. Control the whole path from the prepared medium to the reported result: identify what is introduced, what is removed, what reaches the analytical instrument and which volume the calculation represents.

This article develops an operating checklist for batch-vessel dissolution tests, chiefly basket and paddle configurations. It separates equipment status from product-method controls and uses an explicitly simulated mass balance to explain sampling with and without medium replacement. It does not prescribe a universal temperature, agitation rate, sampling schedule or medicinal-product acceptance limit.

Define the method and allocate responsibility

Before setup, identify the product, strength, lot, dosage form and applicable procedure version. Confirm apparatus, accessories, medium, starting volume, agitation, test duration and whether the result is a single point or a profile. “Use the usual dissolution method” leaves too many decisions to the analyst and makes a later comparison difficult to interpret.

Keep three evidence packages connected: the released apparatus configuration, the validated or verified product procedure and the records of this particular run. Equipment qualification supports defined instrument capabilities. It does not prove that a new filter, changed medium or different sample-holding period is suitable. Conversely, acceptable product results do not establish every mechanical characteristic.

ICH Q2(R2) distinguishes the dissolution step from the subsequent quantitative determination in its dissolution example. Q14 links procedure knowledge to controls. For daily work, turn those distinctions into responsibilities: who prepares and releases medium, confirms start conditions, operates sampling, checks the analytical finish and reviews calculations? Define the response when one control is not satisfied before testing begins.

Use the current applicable compendial text, monograph and approved procedure to establish conditions. The USP public introductions identify relevant chapters but are not the complete current methods. FDA’s 1997 guidance provides historical operating context for immediate-release products; its numerical examples and equipment recommendations must not be transferred indiscriminately to other products or qualification pathways.

Prepare the medium and justify deaeration

Record the water and reagent identities, grades, lots, quantities, preparation sequence, final volume and permitted holding period. Where relevant, identify buffer or surfactant concentration and the temperature at which pH and volume are established. A correct pH alone does not show that two media have the same composition or buffering capacity.

Use suitable, controlled measurement equipment. Trace the medium batch to individual vessels and retain actual checks rather than only a “prepared correctly” signature. If a concentrate is diluted automatically, account for its homogeneity, stability and dilution settings. A dispensing record without the source solution’s identity cannot reconstruct the medium used.

Establish deaeration requirements during method development and follow the approved process in routine work. Gas bubbles can change contact with the dosage form; removing them is not an opportunity to select whichever treatment improves the result. Gao and colleagues studied dissolved gases and deaeration with a particular prednisone system; that evidence does not define a universal gas limit for all formulations.

Document the handling after deaeration: transfer, mixing, storage and the interval before use. A treatment performed earlier does not by itself describe the medium at the moment of testing. When changing preparation equipment or batch size, assess the complete preparation-to-use sequence. Use appropriate protection and approved equipment for hot liquids, vacuum and glass; never improvise a sealed heated vessel.

Confirm temperature and starting conditions

Check the medium at the appropriate location and after the defined equilibration process. The bath-controller indication and the actual vessel medium are different observations. Link the thermometer or probe to its calibration status, measurement position and time. The operating instruction should explain when readings are taken and how the probe is handled without disturbing the test.

Account for the real load: filled vessels, covers, installed accessories and the sequence of additions. Medium brought to an initial temperature can change during transfer or loading. Replacement medium may introduce a further thermal disturbance. Set acceptance and response from the applicable procedure rather than from an apparently stable display alone.

Before introducing units, confirm correct vessel and sample mapping, authorised agitation settings, timer readiness and available sampling capacity. With staggered introduction, each vessel needs the correct reference time. A single clock on the wall is not evidence that every actual withdrawal met its own schedule.

Resolve an unmet starting condition before proceeding where the procedure requires it. If a problem becomes apparent after start, preserve the original chronology, identify affected vessels and follow the deviation process. Do not backdate an equilibration check or redefine the start time to make records fit the expected result.

Introduce the dosage form reproducibly

Define how units are handled, placed and brought into contact with the medium relative to agitation and timing. Preserve unit identity and avoid accidental damage or uncontrolled moisture exposure during preparation. Use only the sinker, basket or other accessory specified or justified for that procedure; an accessory changes the test configuration.

Record relevant observations by vessel and time: floating, sticking, bubbles, unusual movement or a mound of particles beneath a paddle, often called coning. Describe what was seen separately from the proposed cause. “Coning observed” is evidence of behaviour; “instrument failed” requires further support.

Yoshida and colleagues found formulation-dependent effects when investigating different apex-vessel geometries. Their work reinforces the need to evaluate changes rather than assuming that removing a visible mound preserves the method’s meaning. Do not increase speed, push a floating unit down or replace the vessel during a routine run merely to obtain a more favourable profile.

Arrange observation so that it does not itself disturb the experiment. Keep tools clear of rotating parts and follow the approved stop state before intervention. If a handling error occurs, document the actual event and its timing. An explanatory note written contemporaneously is more useful than a later description reconstructed from the final curve.

Withdraw, filter and preserve representative samples

Specify the sampling position, nominal time, permitted timing window and actual volume removed. Identify whether the recorded time describes aspiration from the vessel or arrival in a collection vial. Preserve vessel-to-vial mapping throughout transfer, filtration, dilution and analysis, including any manual relabelling or sequence changes.

Evaluate the selected filter for the actual analyte, medium, matrix and concentration range. Particle removal and dissolved-analyte recovery are different questions. USP’s filter FAQ discusses adsorption and establishing a suitable discard volume; a clear filtrate alone is not proof of suitability. Do not import another product’s filter material or discard instruction without evidence.

Include every nonreturned volume in the withdrawal ledger: analytical aliquot, filter conditioning, line purge and discarded excess where these originate from the vessel. If the procedure replaces medium, record the amount and timing of replacement. A vial containing a small aliquot may represent a much larger net withdrawal from the vessel.

Control the time between withdrawal, separation of undissolved material and measurement. Use justified containers, storage conditions and holding periods. Do not assume that a filtered sample remains chemically unchanged indefinitely. Record dilutions and recover the concentration in the vessel before using it in a mass-balance calculation.

Verify the automated sampling path

Map probe, filter, tubing, valves, pump and collection position for each channel. Identify the installed materials and lengths, the volume retained in the path and the cleaning configuration. A correct pump setting does not demonstrate that the collected sample represents the vessel at the nominal sampling time.

Challenge the relevant functions separately: transferred volume, timing, recovery, carryover and sample identity. A homogeneous solution can help examine transfer independently of tablet variability. A product comparison is then needed where the change can affect dissolution itself, for example through probe residence or a different sampling position. Define the study and acceptance basis before comparison.

Compare manual and automated procedures under a justified design. Simply withdrawing twice from one vessel can alter volume and hydrodynamics, so document how the comparison avoids creating the difference it seeks to measure. Cover the concentrations and operating conditions relevant to use instead of relying only on one convenient solution.

Specify whether liquid is discarded, replaced or recirculated. Recirculation creates a different accounting problem, including the line inventory and the possibility of returning altered liquid. The simple equations below do not cover it. Control software settings and calculation versions, and reconcile programmed events with the audit trail or other original event records.

Reconcile mass balance, results and the run record

For a well-mixed batch vessel with stable dissolved analyte, the accounted mass is the mass still in the vessel plus the mass removed in earlier samples. The following equations assume representative instantaneous withdrawals, no evaporation, adsorption, degradation or unrecorded losses, and no analyte in replacement medium. They also exclude recirculation, medium changes and multiphase procedures.

Let C_n be the vessel concentration immediately before withdrawal n, expressed in mg/mL, and v_i the complete nonreturned volume of an earlier withdrawal, in mL. Concentrations must already include valid dilution corrections. With exact equal-volume replacement after each earlier withdrawal, the starting vessel volume V₀ stays constant:

M_n = C_nV₀ + Σ_i<nC_iv_i

Without replacement, the remaining volume before withdrawal n is V₀ − Σ_i<nv_i:

M_n = C_n(V₀ − Σ_i<nv_i) + Σ_i<nC_iv_i

Each concentration-volume product has units of mg. The sums include only earlier withdrawals, because the current sample is still included in the vessel mass immediately before its removal. Counting it again double-counts that mass. A percent released requires the correctly defined product denominator and any applicable potency or chemical-form corrections; those are not supplied by this mass balance.

Simulated control case: already dissolved analyte

This arithmetic example contains no tablet and no further dissolution. Initially 50.000 mg is fully dissolved in 1000 mL; two successive withdrawals each remove 10 mL. Values are simulated exactly, with perfect mixing and no losses. They demonstrate accounting, not recommended test conditions or an experimentally validated method.

With replacement, fresh blank medium lowers concentration after each withdrawal. Without replacement, concentration stays constant in this deliberately static example while the vessel volume falls. Applying the replacement equation to the no-replacement data would yield 51.000 mg, an impossible gain under these assumptions. Independent stepwise subtraction and the cumulative equations both recover 50.000 mg.

Before, during and after: the operating checklist

• Before: confirm procedure and apparatus status; release medium; verify filters, containers, timing, temperature and sample mapping; select the correct calculation mode.
• During: record actual introduction and withdrawal times, volumes, replacements, temperature checks and observations; retain alarms and departures from the procedure.
• After: reconcile samples and volume records; check analytical suitability and dilution factors; verify formulas and units; review individual profiles and deviations; retain original data before cleaning and release of the apparatus.

An unexpected profile calls for a structured investigation, not repeated testing until it passes. Check operating evidence without presuming that either product or instrument is responsible. Preserve original results, evaluate the significance of an identified error and distinguish authorised investigative work from reportable retesting under the applicable quality procedure.

Sources and applicability

Source review: 29 September 2026. Consulted relevant FDA/Q2(R2)/Q14 sections, USP public introductions and indexed institutional filter FAQ, Gao’s abstract and Yoshida’s updated publisher article. Current full USP/Ph. Eur. chapters and a product-specific monograph were not accessed. Historical proposed USP material was excluded as a current requirement. Tables, checklist and calculation below are original GuideGxP reasoning tools, not reproduced compendial procedures.

1. USP. ⟨711⟩ Dissolution. Public preview, 2023 citation; full current chapter not accessed.
2. USP. ⟨1092⟩ The Dissolution Procedure: Development and Validation. Public introduction, 2023 citation; full current chapter not accessed.
3. USP. Preguntas frecuentes: ⟨1092⟩ Procedimiento de Disolución: Desarrollo y Validación. Institutional indexed FAQ text consulted; direct access restricted.
4. FDA. Dissolution Testing of Immediate Release Solid Oral Dosage Forms. Guidance, August 1997; operating-method context, not a universal current equipment qualification protocol.
5. ICH / FDA. Q2(R2) Validation of Analytical Procedures. Final guidance, March 2024; dissolution example and analytical measurement validation.
6. ICH / FDA. Q14 Analytical Procedure Development. Final guidance, March 2024; robustness and analytical procedure control strategy.
7. Gao Z et al. Effects of deaeration methods on dissolution testing in aqueous media: a study using a total dissolved gas pressure meter. J Pharm Sci. 2006;95:1606–1613. doi:10.1002/jps.20622. Abstract consulted.
8. Yoshida H et al. Effects of Apex Size on Dissolution Profiles in the USP II Paddle Apparatus. AAPS PharmSciTech. 2024;25:9. Updated publisher article; abstract and discussion consulted.
9. FDA. Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production. Guidance, May 2022; investigation and retesting principles.

Related Pharma Lab articles

• Dissolution apparatus qualification
• Analytical instrument qualification and USP ⟨1058⟩
• Qualification, method validation and system suitability